Large cell lung carcinoma (LCLC) is a type of non-small cell lung cancer. This type of tumor is characterized by an aggressive course and high metastatic capacity. Unlike other types of lung cancer, such as squamous cell and adenocarcinoma, LCLC develops from large cells, which determines the clinical and morphological features of the disease. Large cell carcinoma is often diagnosed at late stages, which is associated with low specificity of symptoms at early stages. The clinical picture includes clear respiratory problems, general malaise, weight loss and sluggish course of the disease, which together leads to difficulty in diagnosis at early stages.
History of the disease and interesting historical facts
Large cell lung carcinoma was first described in the literature in the mid-20th century, when the attention of the medical community began to focus on the study of various types of lung tumors. In the 1940s, scientists identified the main morphological characteristics of LCC, which allowed them to better understand the mechanism of its development and progression. The popularity of LCC as a disease under study increased in the 1970s, when a link was found between smoking and increased incidence of mid- and large-cell lung cancer. Over time, LCC has become a better-studied tumor given the molecular changes that certain gene mutations lead to.
Epidemiology
According to the latest data from the World Health Organization, SCC accounts for 10-15% of all lung cancer cases, making it one of the most common forms of the disease among non-small cell cancers. According to statistics, the incidence of SCC reaches 3-8 cases per 100,000 population per year, with the highest prevalence among men over 50 years of age. According to research, the incidence rate increases significantly in settlements with high levels of air pollution and smoking. Forecasts show that the expected incidence will grow in the coming years, which requires enhanced monitoring and preventive measures.
Genetic predisposition to this disease
Large cell lung carcinoma has a genetic predisposition. Numerous studies have identified mutations in a number of key genes that contribute to the development and progression of this type of cancer. The most important of these include:
- TP53 – genes responsible for inhibition of tumor growth and DNA repair;
- KRAS – mutations in this gene often accompany smoking and give the tumor the ability to grow aggressively;
- EGFR – its activation leads to stimulation of cell division;
- ALK – transformations associated with this gene are also observed in other types of lung cancer.
These changes can significantly affect the mechanism of disease development, its aggressiveness and resistance to therapy.
Risk factors for the development of this disease
Large cell lung carcinoma develops under the influence of many factors. The most significant are:
- Smoking is the main cause of CKD, increasing the risk of the disease by 20-30 times;
- Occupational hazards – exposure to asbestos, radon and other carcinogenic chemicals;
- Environmental pollution – high levels of pollutants such as hydrocarbons;
- Chronic lung diseases – such as chronic bronchitis and emphysema – increase the risks;
- Family history – patients with a hereditary predisposition have an increased risk of developing the disease.
Understanding these factors allows for improved prevention and early detection strategies.
Diagnosis of this disease
Diagnosis of large cell lung carcinoma involves many methods and technologies:
- Main symptoms:
- Cough, including coughing up blood;
- Shortness of breath and wheezing;
- Chest pain;
- Persistent general malaise;
- Weight loss.
- Laboratory tests:
- Complete blood count – may show anemia;
- Biochemical analysis – reveals markers of inflammation.
- Radiological examinations:
- X-ray examination;
- Computed tomography (CT) – allows visualization of the tumor;
- Pet scanning – used to assess prevalence;
- Other types of diagnostics:
- Bronchoscopy with biopsy – to obtain tissue samples;
- Cytological examination – studies the cellular composition.
- Differential diagnosis – the main task is to exclude other forms of cancer and lung diseases.
Effective diagnostics is a key step in choosing the right treatment and assessing the prognosis of the disease.
Treatment
Treatment for large cell lung carcinoma depends on the stage of the disease and the patient's general condition. The main methods include:
- General treatment – involves a comprehensive approach that includes surgery, chemotherapy and radiotherapy;
- Pharmacological treatment – combines the use of modern chemotherapy drugs, such as:
- Cisplatin, Carboplatin;
- Doxorubicin;
- Gemcitabine;
- Surgical treatment involves removing the tumor in the early stages, in the absence of metastases;
- Other treatments include immunotherapy, targeted therapy that targets specific molecules.
Effective treatment requires a multidisciplinary approach involving oncologists, chemotherapists and radiologists.
List of medications used to treat this disease
- Cisplatin;
- Carbaoplatin;
- Doxorubicin;
- Gemcitabine;
- Paclitaxel;
- Erythropoietin - for the treatment of anemia;
- Immunomodulators for combination therapy.
These drugs are used both in monotherapy and in combination to achieve maximum effectiveness.
Disease monitoring
Disease monitoring includes regular follow-up examinations and evaluation of treatment effectiveness. It is important to monitor the dynamics of the disease using:
- Systematic radiological examination;
- Tests for tumor marker levels;
- Regular consultations with your doctor.
The prognosis of CCC depends on many factors, including the stage of the disease at diagnosis, the patient's age, and his or her overall health. Complications may include metastasis to other organs, pleurisy, and respiratory distress.
Age-related features of the disease
Large cell lung carcinoma exhibits different age-related features depending on the patient group. In older people, the disease may proceed more aggressively, with an increased probability of late stage presentation. At the same time, in younger patients, errors in diagnosis and dependence on a cumbersome clinical picture are often observed. Young people with LCC may also be carriers of genetic mutations, which necessitates adaptation of treatment methods.
Questions and Answers
- What are the main symptoms of large cell lung carcinoma? The main symptoms include cough, shortness of breath, chest pain, weight loss and general malaise.
- How is CCC diagnosed? Diagnosis includes radiological examinations, laboratory tests and biopsy.
- What are the risk factors for developing this disease? Major risk factors include smoking, exposure to carcinogens, and lung disease.
- What is the treatment for CCC? Treatment may include surgery, chemotherapy, and immunotherapy, depending on the stage of the disease.
- What is the prognosis after diagnosis? The prognosis depends on the stage of the disease at the time of diagnosis, but CCC is highly aggressive and has a high risk of metastasis.
Advice from Dr. Oleg Korzhikov
Doctor Oleg Korzhikov recommends not to delay seeing a doctor if you suspect large cell lung carcinoma, as early diagnosis significantly improves the prognosis. Regular preventive diagnostics are also important for the risk group, especially among smokers. In case of diagnosis, the key point remains the choice of an effective treatment regimen, including a multidisciplinary approach and modern therapeutic methods.
